{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-020507","form_type":"8-K","ticker":"IMMX","cik":"0001873835","company_name":"Immix Biopharma, Inc.","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.413750+00:00","generated_at":"2026-06-14T05:19:10.016945+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Immix Biopharma shareholders elect 7 directors, ratify auditor, approve equity plan","bullets":["All seven director nominees elected: Rachman, Morris, Hsu, Marquet, Adams, Ng, Buchan.","Ratification of KMJ Corbin as auditor approved: 9,497,865 for, 36,813 against, 7,792 abstain.","Amended 2021 Omnibus Equity Incentive Plan approved: 7,315,768 for, 295,959 against, 10,792 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-020507","json":"https://secwatch.observer/filing/0001493152-23-020507.json","markdown":"https://secwatch.observer/filing/0001493152-23-020507.md","text":"https://secwatch.observer/filing/0001493152-23-020507.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223020507/0001493152-23-020507-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223020507/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T05:19:10.016945+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3b9a6f8c8aea31da9b7380084dd291340c21d9e3","claim":"Immix Biopharma, Inc. shareholders approved Ratification of KMJ Corbin & Company LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-07 meeting.","evidence_excerpt":"The result of the votes to approve KMJ was as follows: For Against Abstain Broker Non-Votes 9,497,865 36,813 7,792 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223020507/0001493152-23-020507-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"},{"claim_id":"98a7421b4d2020f1399d8232dac3f85c203f7dbf","claim":"Immix Biopharma, Inc. shareholders approved Election of seven directors at the 2023-06-07 meeting.","evidence_excerpt":"All of the seven nominees for director were elected to serve until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified, or until such director’s earlier resignation, removal or death. The result of the votes to elect the seven directors were as follows: Directors For Withhold Broker Non-Votes Ilya Rachman 7,600,072 22,447 1,919,951 Gabriel Morris 7,457,001 165,518 1,919,951 Jason Hsu 7,560,452 62,066 1,919,952 Magda Marquet 7,491,766 130,753 1,919,951 Helen C. Adams 7,488,906 133,612 1,919,952 Carey Ng 7,585,080 37,438 1,919,952 Jane Buchan 7,495,642 126,877 1,919,951","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223020507/0001493152-23-020507-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"},{"claim_id":"eeb572c0f365ca526446ee4eacd76780edae6716","claim":"Immix Biopharma, Inc. shareholders approved Approval of Immix Biopharma, Inc. Amended and Restated 2021 Omnibus Equity Incentive Plan at the 2023-06-07 meeting.","evidence_excerpt":"The result of the votes to approve the Amended and Restated 2021 Plan was as follows: For Against Abstain Broker Non-Votes 7,315,768 295,959 10,792 1,919,951","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223020507/0001493152-23-020507-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}